Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03885895Phase 1Unknown
Phase 1, randomised, single-blind trial of tranexamic acid in ephelides, sponsored by Kasr Al Ainy Hospital. Primary endpoints: Pigmentation and Severity Index at 1 year and Melanin Index at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03885895.